Literature DB >> 2730565

Purification and characterization of myosin light-chain kinase from the rat pancreas.

M Bissonnette1, D Kuhn, P de Lanerolle.   

Abstract

We have partially purified a protein kinase from rat pancreas that phosphorylates two light-chain subunits of pancreatic myosin, a doublet with components of 18 and 20 kDa. This protein kinase was purified approx. 1000-fold by sequential (NH4)2SO4 fractionation, gel filtration, ion-exchange and affinity chromatography on calmodulin-Sepharose 4B. The resultant enzyme preparation is free of cyclic AMP-dependent protein kinase, protein kinase C and calmodulin-dependent type I or II kinase activities. The purified protein kinase is completely dependent on Ca2+ and calmodulin, and phosphorylates a 20 kDa light-chain subunit of intact gizzard myosin, suggesting that it belongs to a class of enzymes known as myosin light-chain kinase (MLCK). The apparent Km values of the putative pancreatic MLCK for ATP (73 microM), gizzard myosin light chains (18 microM) and calmodulin (2 nM) are similar to those reported for MLCKs isolated from smooth muscle, platelet and other sources. The enzyme is half-maximally activated at a free Ca2+ concentration of 2.5 microM. A single component of the affinity-purified kinase reacts with antibodies to turkey gizzard MLCK. The apparent molecular mass of this component is 138 kDa. Immunoprecipitation of a pancreatic homogenate with these antibodies decreases calmodulin-dependent kinase activity for pancreatic myosin by over 85%. The immunoprecipitate contains a single electrophoretic band of 138 kDa. Tryptic phosphopeptide analyses of pancreatic myosin, phosphorylated by either gizzard or pancreatic MLCK, are identical. Thus the enzyme that we have purified from rat pancreas is a MLCK, as judged by (1) absolute dependence on Ca2+ and calmodulin, (2) high affinity for calmodulin, (3) narrow substrate specificity for the light-chain subunit of myosin, and (4) reactivity with antibodies to turkey gizzard MLCK. These studies establish the existence of a pancreatic MLCK which may be responsible for regulating myosin phosphorylation and enzyme secretion in situ.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730565      PMCID: PMC1138427          DOI: 10.1042/bj2580739

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Ultrastructural localization of cytoskeletal proteins in pancreatic secretory cells.

Authors:  M Bendayan
Journal:  Can J Biochem Cell Biol       Date:  1985-06

2.  Control of stimulus-secretion coupling in adrenal medullary chromaffin cells by microfilament-specific macromolecules.

Authors:  J E Friedman; P I Lelkes; K Rosenheck; A Oplatka
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

3.  Ca2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-Sepharose affinity chromatography.

Authors:  R Gopalakrishna; W B Anderson
Journal:  Biochem Biophys Res Commun       Date:  1982-01-29       Impact factor: 3.575

4.  Evidence for the existence of actomyosin ATPase in the rat pancreas. Isolation and biochemical characterization.

Authors:  A Vandermeers; M C Vandermeers-Piret; A Hepburn; J Rathe; J Christophe
Journal:  Eur J Biochem       Date:  1982-01

5.  Effects of high concentrations of secretagogues on the morphology and secretory activity of the pancreas: a role for microfilaments.

Authors:  D B Burnham; J A Williams
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

6.  Stimulus-secretion coupling in exocrine pancreas; possible role of calmodulin.

Authors:  S Heisler; L Chauvelot; D Desjardins; C Noel; H Lambert; L Desy-Audet
Journal:  Can J Physiol Pharmacol       Date:  1981-09       Impact factor: 2.273

7.  Relation between free cytosolic calcium and amylase release by pancreatic acini.

Authors:  D L Ochs; J I Korenbrot; J A Williams
Journal:  Am J Physiol       Date:  1985-09

8.  Characterization of antibodies to smooth muscle myosin kinase and their use in localizing myosin kinase in nonmuscle cells.

Authors:  P de Lanerolle; R S Adelstein; J R Feramisco; K Burridge
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  Characterization of myosin light-chain kinase from bovine adrenal medulla.

Authors:  I M Serventi; C J Coffee
Journal:  Arch Biochem Biophys       Date:  1986-03       Impact factor: 4.013

10.  Interaction of calmodulin with myosin light chain kinase and cAMP-dependent protein kinase in bovine brain.

Authors:  D R Hathaway; R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

View more
  5 in total

1.  Molecular characterization of a mammalian smooth muscle myosin light chain kinase.

Authors:  P J Gallagher; B P Herring; S A Griffin; J T Stull
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

2.  Altered gene expression in cerulein-stimulated pancreatic acinar cells: pathologic mechanism of acute pancreatitis.

Authors:  Ji Hoon Yu; Joo Weon Lim; Hyeyoung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

3.  Phosphorylation of smooth muscle myosin by type II Ca2+/calmodulin-dependent protein kinase.

Authors:  A M Edelman; W H Lin; D J Osterhout; M K Bennett; M B Kennedy; E G Krebs
Journal:  Mol Cell Biochem       Date:  1990-09-03       Impact factor: 3.396

4.  The carboxyl terminus of the smooth muscle myosin light chain kinase is expressed as an independent protein, telokin.

Authors:  P J Gallagher; B P Herring
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

5.  Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity.

Authors:  M O Shoemaker; W Lau; R L Shattuck; A P Kwiatkowski; P E Matrisian; L Guerra-Santos; E Wilson; T J Lukas; L J Van Eldik; D M Watterson
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.